Evidence map›Paper›PMID 39941616›Full record

ArticleJournal of clinical medicine2025

Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR).

Elvis Ruznic, Marisa Klebermass, Barbara Zellinger, Brigitte Langer, Brane Grambozov, Ayurzana Purevdorj, Josef Karner, Georg Gruber, Markus Stana, Danijela Minasch and 8 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Journal of thoracic disease · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Elvis RuznicDepartment of Radiation Oncology, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0001-7686-1008
Marisa KlebermassKlinikum Ottakring, 1090 Vienna, Austria.
Barbara ZellingerDepartment of Radiation Oncology, Paracelsus Medical University, 5020 Salzburg, Austria.
Brigitte LangerKlinikum Ottakring, 1090 Vienna, Austria.
Brane GrambozovDepartment of Radiation Oncology, Paracelsus Medical University, 5020 Salzburg, Austria.
Ayurzana PurevdorjKlinikum Hietzing-Rosenhügel, 1090 Vienna, Austria.
Josef KarnerDepartment of Radiation Oncology, Paracelsus Medical University, 5020 Salzburg, Austria.
Georg GruberOrdensklinikum Linz, 4020 Linz, Austria.
Markus StanaDepartment of Radiation Oncology, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0002-0155-0384
Danijela MinaschDepartment of Radiation Oncology, Comprehensive Cancer Centre, Medical University Innsbruck, 6020 Innsbruck, Austria.
Karoline KirchhammerKlinikum Klagenfurt, 9020 Klagenfurt, Austria.
Claudia SteffalKlinikum Favoriten, 1100 Vienna, Austria.ORCID 0009-0001-3845-1267
Heidi StranzlDepartment of Radiation Oncology, Comprehensive Cancer Centre, Medical University Graz, 8036 Graz, Austria.
Raphaela MoosbruggerDepartment of Pulmonology, Paracelsus Medical University, 1090 Salzburg, Austria.
Petra FeursteinKlinikum Ottakring, 1090 Vienna, Austria.
Karin DieckmannDepartment of Radiation Oncology, Comprehensive Cancer Centre, Medical University Vienna, 1090 Vienna, Austria.
Franz ZehentmayrDepartment of Radiation Oncology, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0001-5931-3907
ALLSTAR Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chemoradiotherapydurvalumabKRAS G12CKRAS mutationradiation dose escalation

Identifiers

PMID39941616
PMCPMC11818499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.